Financial Advisor
Scriptcycle, LLC
M&A Advisory
Has Been Acquired By
Transaction Details
- On August 31, 2020, GoodRx, Inc. (“GoodRx”) completed its acquisition of Scriptcycle, LLC (“Scriptcycle”) in a transaction valued at up to $63.1 million
- GoodRx paid $60.1 million related to the acquisition at close
- Additionally, up to $3.0 million of incremental compensation payments may be payable based on achievement of certain post-acquisition revenue targets
- GoodRx expects this acquisition to help expand business capabilities, particularly in respect to its prescription offering
About the company
Scriptcycle, LLC
Scriptcycle uses advanced technology to provide a national network of pharmacies with comprehensive, real-time prescription pricing and processing. The Company’s built-in prescription pricing logic is designed to update price points as drug data and pharmaceutical wholesale prices change, resulting in lower costs to patients and more current pricing for pharmacies.
GoodRx Holdings, Inc.
GoodRx’s mission is to help Americans get the healthcare they need at a price they can afford. GoodRx’s leading digital platform for consumer healthcare products and services connects consumers with affordable and convenient prescriptions and medical care, including telehealth, mail order prescriptions, doctor visits, and lab tests. GoodRx has helped Americans save over $20 billion since 2011 and was the #1 most downloaded medical app in the last three years.
Source: GoodRx’s Form S-1/A, GoodRx’s Press Release, and Scriptcycle’s website
-
This material has been prepared solely for informative purposes as of its stated date and is not a solicitation, or an offer, to buy or sell any security. It does not purport to be a complete description of the securities, markets or developments referred to in the material. Information included in the material was obtained from sources which we consider reliable, but we have not independently verified such information and do not guarantee that it is accurate or complete. No subsequent publication or distribution of this material shall mean or imply that any such information or opinion remains current at any time after the stated date of the material. We do not undertake to advise you of any changes in any such information or opinion. Additional information is available upon request.
-
“Stephens” is the brand name for a family of independent privately held financial services firms, including Stephens Europe Limited, which is authorized and regulated by the Financial Conduct Authority (Registered office 36-38 Cornhill, London, EC3V 3NG, Registered number 8817024) and Stephens Inc. which is regulated by the United States Securities and Exchange Commission and the Financial Industry Regulatory Authority (Home Office: 111 Center Street, Little Rock, AR USA, 501-377-2000). Stephens Inc. is a member of NYSE and SIPC. For more information, visit www.stephens.com. © 2020 Stephens